The preclinical and clinical activity of aviscumine: A potential anticancer drug
Keywords: Aviscumine; Recombinant mistletoe lectin; Ribosome-inactivating proteins; CD75s; Solid tumours; Cancer therapy; Cancer immunotherapy;